pharma-company /Medicinal products /Active ingredients

Rx · PZN 19253838, 20169250

SKYRIZI 180 mg solution for injection in a cartridge On-Body-Injek.

German trade nameSKYRIZI 180 mg Injektionslösung in einer Patrone On Body Injektion

Active ingredientRisankizumabPharmaceutical formSolution for injection/infusion

Consistently available

8.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Average purchase price (B2B)

~ €2,118

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

SKYRIZI 180 mg solution for injection in a cartridge On-Body-Injek. is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

SKYRIZI 180 mg solution for injection in a cartridge On-Body-Injek. contains the active ingredient Risankizumab and comes as Solution for injection/infusion. 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 8.6 out of 10. The best-available pack was consistently available.


Pack sizes · 2 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
192538389.48.6~ €2,118
201692500.00.0~ €2,118

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 2 recorded PZNs.